Indivior (LON:INDV) Trading 8.1% Higher

Indivior PLC (LON:INDVGet Free Report) traded up 8.1% during trading on Thursday . The company traded as high as GBX 848 ($10.86) and last traded at GBX 843 ($10.80). 1,729,744 shares traded hands during mid-day trading, an increase of 223% from the average session volume of 534,858 shares. The stock had previously closed at GBX 780 ($9.99).

Analysts Set New Price Targets

Separately, Deutsche Bank Aktiengesellschaft cut their price target on Indivior from GBX 2,350 ($30.10) to GBX 1,500 ($19.21) and set a “buy” rating for the company in a research note on Tuesday.

Read Our Latest Report on INDV

Indivior Trading Up 8.1 %

The firm has a fifty day simple moving average of GBX 1,310.67 and a two-hundred day simple moving average of GBX 1,415.90. The stock has a market cap of £1.14 billion, a PE ratio of 28,100.00, a PEG ratio of -5.57 and a beta of 0.06. The company has a current ratio of 0.93, a quick ratio of 1.52 and a debt-to-equity ratio of 2,790.00.

About Indivior

(Get Free Report)

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.

Featured Stories

Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.